RegentAtlantic Capital’s Procter & Gamble PG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $12.6M | Buy |
100,063
+1,317
| +1% | +$187K | 0.38% | 37 |
|
|
2022
Q2 | $14.2M | Buy |
98,746
+7,019
| +8% | +$1.05M | 0.47% | 30 |
|
|
2022
Q1 | $14M | Buy |
91,727
+10,610
| +13% | +$1.66M | 0.4% | 43 |
|
|
2021
Q4 | $13.3M | Buy |
81,117
+4,533
| +6% | +$673K | 0.37% | 43 |
|
|
2021
Q3 | $10.7M | Buy |
76,584
+8,135
| +12% | +$1.15M | 0.32% | 52 |
|
|
2021
Q2 | $9.24M | Buy |
68,449
+638
| +0.9% | +$86.3K | 0.28% | 61 |
|
|
2021
Q1 | $9.18M | Buy |
67,811
+15,964
| +31% | +$2.08M | 0.31% | 59 |
|
|
2020
Q4 | $7.21M | Buy |
51,847
+9,209
| +22% | +$1.29M | 0.29% | 67 |
|
|
2020
Q3 | $5.93M | Buy |
42,638
+6,382
| +18% | +$847K | 0.27% | 74 |
|
|
2020
Q2 | $4.33M | Buy |
36,256
+5,532
| +18% | +$645K | 0.24% | 91 |
|
|
2020
Q1 | $3.38M | Sell |
30,724
-17,958
| -37% | -$2.16M | 0.26% | 89 |
|
|
2019
Q4 | $6.08M | Buy |
48,682
+2,887
| +6% | +$353K | 0.37% | 70 |
|
|
2019
Q3 | $5.7M | Sell |
45,795
-424
| -0.9% | -$50.1K | 0.38% | 71 |
|
|
2019
Q2 | $5.07M | Sell |
46,219
-322
| -0.7% | -$34.3K | 0.34% | 78 |
|
|
2019
Q1 | $4.84M | Buy |
46,541
+1,222
| +3% | +$119K | 0.34% | 79 |
|
|
2018
Q4 | $4.17M | Buy |
45,319
+17,067
| +60% | +$1.53M | 0.35% | 86 |
|
|
2018
Q3 | $2.35M | Buy |
28,252
+872
| +3% | +$71.3K | 0.18% | 139 |
|
|
2018
Q2 | $2.14M | Sell |
27,380
-951
| -3% | -$71.6K | 0.18% | 136 |
|
|
2018
Q1 | $2.25M | Sell |
28,331
-2,759
| -9% | -$230K | 0.19% | 132 |
|
|
2017
Q4 | $2.86M | Sell |
31,090
-984
| -3% | -$88.5K | 0.23% | 121 |
|
|
2017
Q3 | $2.92M | Buy |
32,074
+511
| +2% | +$46.5K | 0.25% | 113 |
|
|
2017
Q2 | $2.75M | Sell |
31,563
-628
| -2% | -$55.4K | 0.25% | 114 |
|
|
2017
Q1 | $2.89M | Buy |
32,191
+237
| +0.7% | +$21K | 0.27% | 105 |
|
|
2016
Q4 | $2.69M | Sell |
31,954
-425
| -1% | -$36.2K | 0.26% | 104 |
|
|
2016
Q3 | $2.91M | Buy |
32,379
+694
| +2% | +$60.3K | 0.3% | 89 |
|
|
2016
Q2 | $2.68M | Sell |
31,685
-954
| -3% | -$78.3K | 0.26% | 94 |
|
|
2016
Q1 | $2.69M | Sell |
32,639
-280
| -0.9% | -$22.6K | 0.3% | 87 |
|
|
2015
Q4 | $2.61M | Sell |
32,919
-5,002
| -13% | -$382K | 0.28% | 101 |
|
|
2015
Q3 | $2.73M | Sell |
37,921
-4,478
| -11% | -$336K | 0.26% | 92 |
|
|
2015
Q2 | $3.32M | Sell |
42,399
-2,970
| -7% | -$239K | 0.3% | 89 |
|
|
2015
Q1 | $3.72M | Sell |
45,369
-2,129
| -4% | -$183K | 0.33% | 83 |
|
|
2014
Q4 | $4.33M | Sell |
47,498
-929
| -2% | -$81.7K | 0.37% | 70 |
|
|
2014
Q3 | $4.05M | Sell |
48,427
-5,020
| -9% | -$411K | 0.38% | 72 |
|
|
2014
Q2 | $4.2M | Sell |
53,447
-3,305
| -6% | -$266K | 0.39% | 71 |
|
|
2014
Q1 | $4.57M | Sell |
56,752
-6,160
| -10% | -$485K | 0.45% | 59 |
|
|
2013
Q4 | $5.12M | Buy |
62,912
+491
| +0.8% | +$40K | 0.49% | 52 |
|
|
2013
Q3 | $4.72M | Sell |
62,421
-3,299
| -5% | -$263K | 0.51% | 47 |
|
|
2013
Q2 | $5.06M | Buy |
+65,720
| New | +$5.16M | 0.6% | 45 |
|
Other funds holding PG
RegentAtlantic Capital's PG Position: Q3 2022 in Review
RegentAtlantic Capital increased its Procter & Gamble (PG) stake by 1.3% in Q3 2022, buying an estimated $187K and bringing the position to 100,063 shares worth $12.6M. The position accounts for 0.38% of the portfolio, ranked #37.
RegentAtlantic Capital first reported a position in PG in Q2 2013 and has held it in 38 quarters since. The position peaked at $14.2M in Q2 2022. 3,195 funds tracked by Wall St. Rank hold PG as of Q3 2022.
- RegentAtlantic Capital held 100,063 shares of Procter & Gamble worth $12.6M as of Q3 2022.
- RegentAtlantic Capital bought 1,317 Procter & Gamble shares in Q3 2022, an estimated $187K.
- Procter & Gamble made up 0.38% of RegentAtlantic Capital's portfolio in Q3 2022, its #37 holding.
- RegentAtlantic Capital first reported a position in Procter & Gamble in Q2 2013 and has held it in 38 quarters since.
- RegentAtlantic Capital's Procter & Gamble position peaked at $14.2M in Q2 2022.
- 3,195 funds tracked by Wall St. Rank held Procter & Gamble as of Q3 2022.
Based on RegentAtlantic Capital's 13F filing for Q3 2022, filed 14 Nov 2022.